Why People Take Functional Mushrooms
These five mushrooms are sold as "functional" for five different studied reasons, and the strength of human evidence behind each varies enormously, from 25+ controlled trials (Turkey Tail) to zero completed human trials (Chaga). None of them is a general-purpose health booster; each is studied for a specific, narrow effect at a specific dose.
The evidence, compared side by side
The table below names the single trial most often cited for each mushroom's primary use case. It is not the only research behind each species, see the linked hub for the fuller picture, including safety data and named-brand label comparisons.
| Mushroom | Most-studied reason | Key trial and dose | What the evidence shows |
|---|---|---|---|
| Lion's Mane | Cognitive and nerve-support effects | Mori et al., 2009: 3 g/day for 16 weeks in adults with mild cognitive impairment | Cognitive scores improved during treatment and declined again after supplementation stopped. A separate 2023 pilot study in healthy young adults found smaller, mixed results at a lower dose. |
| Reishi | Immune-marker modulation | Chen et al., 2023: 200 mg/day standardized beta-glucan extract for 84 days in healthy adults | T-lymphocyte and NK-cell markers increased measurably. A different trial (Klupp et al., 2016, 3 g/day whole extract, 16 weeks) found no metabolic benefit in adults with diabetes and metabolic syndrome. |
| Cordyceps | Exercise and energy performance | Chen et al., 2010: Cs-4 999 mg/day for 12 weeks in adults 50-75 | Submaximal exercise threshold measures improved in this older, untrained population. Parcell et al., 2004 (3 g/day, 5 weeks, trained cyclists) found no VO2peak or time-trial benefit. |
| Chaga | Antioxidant compounds, traditional use | No completed human clinical trials | Research is limited to animal and lab studies per Memorial Sloan Kettering's clinical summary. Documented case reports link Chaga powder to kidney injury at doses several products sell as a normal serving. |
| Turkey Tail | Immune support alongside cancer treatment | Nakazato et al., 1994: PSK 3 g/day plus chemotherapy vs. chemotherapy alone, 262 gastric cancer patients | 5-year disease-free and overall survival were both significantly higher in the PSK group. This is the largest evidence base on this site (25+ controlled Japanese trials per NCI PDQ), but the trial dose is roughly 6 times what a typical retail capsule delivers. |
Why the evidence varies so much
Two things account for most of the difference between mushrooms in the table above. First, the amount of human trial work varies by orders of magnitude, from Turkey Tail's 25+ controlled trials to Chaga's zero. Second, even where trials exist, the population and dose tested rarely match a general audience or a typical retail serving: Reishi's immune-marker effect was measured in healthy adults at 200 mg/day, not in people with a diagnosed condition at a higher dose, and Turkey Tail's cancer-trial dose of 3 g/day PSK is roughly 6 times what a typical capsule serving delivers. Each mushroom's own dosage and consumption page breaks down that gap in detail.
Extraction and cultivation method matter too. Several products use lab-grown mycelium on grain instead of the wild or cultivated fruiting body the research was conducted on, which can change what compounds end up in the finished product. Each mushroom's hub page compares named brands on exactly this point.
Mushroom coffee: same ingredients, different delivery
Mushroom coffee blends ground coffee with a powdered mushroom extract, most often Lion's Mane, Cordyceps, or Chaga. It is not a shortcut to the same dose as a dedicated supplement: brands disclose the amount of mushroom extract per serving very differently, and a cup of mushroom coffee is often a fraction of the dose used in the clinical trials above. See the Mushroom Coffee hub for label-by-label comparisons.
Frequently Asked Questions
Sources
- Mori et al., 2009, Phytotherapy Research: Double-blind, placebo-controlled trial of Lion's Mane in adults with mild cognitive impairment, 3 g/day for 16 weeks
- Chen et al., 2023, Foods: Randomized, double-blind, placebo-controlled trial: 200 mg/day Reishi beta-glucan extract for 84 days in healthy adults
- Klupp et al., 2016, Scientific Reports: Randomized trial: 3 g/day whole Reishi extract for 16 weeks in adults with type 2 diabetes and metabolic syndrome; no significant cardiovascular risk-factor benefit
- Chen et al., 2010, Journal of Alternative and Complementary Medicine: Double-blind, placebo-controlled trial: Cordyceps Cs-4 999 mg/day for 12 weeks in adults 50-75
- Parcell et al., 2004, International Journal of Sport Nutrition and Exercise Metabolism: Randomized trial: CordyMax Cs-4 3 g/day for 5 weeks in trained endurance cyclists; no significant VO2peak or time-trial benefit
- Nakazato et al., 1994, The Lancet: Randomized trial, 262 gastric cancer patients, chemotherapy plus PSK (3 g/day) vs. chemotherapy alone
- National Cancer Institute, Medicinal Mushrooms (PDQ): Health Professional Version: Summarizes 25+ controlled Japanese PSK/PSP trials, including Nakazato et al. 1994 and Toge & Yamaguchi 2000
- Memorial Sloan Kettering Cancer Center, Chaga Mushroom clinical summary: Summary noting Chaga evidence is limited to animal and in vitro studies, plus documented kidney-injury case reports